Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Vir Biotechnology (VIR) has 3 years of Current Taxes data on file, last reported at $15.3 million in Q1 2023.

• For the quarter ending Q1 2023, Current Taxes fell 96.23% year-over-year to $15.3 million; the trailing twelve-month figure through Mar 2023 stood at $15.3 million (down 96.23% YoY), and the FY2022 full-year result was $15.2 million, up 144.94% from the prior year.
• Current Taxes was little changed at $15.3 million in Q1 2023, from $15.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $404.4 million in Q1 2022 to a low of $6.2 million in Q4 2021.
• A 3-year average of $116.1 million and a median of $56.7 million in 2022 frame the typical range for Current Taxes.
• Across the five-year window, Current Taxes surged 144.94% in 2022 and sank 96.23% in 2023, its largest moves.
• Tracing VIR's Current Taxes over 3 years: stood at $6.2 million in 2021, then jumped by 144.94% to $15.2 million in 2022, then grew by 0.16% to $15.3 million in 2023.
• Business Quant data shows VIR's Current Taxes at $15.3 million in Q1 2023, $15.2 million in Q4 2022, and $98.2 million in Q3 2022.